Peripheral blood cell immunomarkers in the course of methylprednisolone treatment of multiple sclerosis relapses

Folia Neuropathologica

Volumn 46, Issue 2, 2008, Pages 134-138

  Michałowska Wender, Grazyna ^a,b   Wender, Mieczysław ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Immunomarkers; Methylprednisolone treatment; Multiple sclerosis

Indexed keywords

CASPASE; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; METHYLPREDNISOLONE SODIUM SUCCINATE; MONOCLONAL ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD DONOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; PHAGOCYTOSIS; RELAPSE;

EID: 48049108903     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Airla N, Luomala M, Elovaara I, Kettunen E, Knuutila S, Lehtimäki T. Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis. Preliminary results. J Neurol 2004; 251: 1215-1219.
2. Elovaara I, Kuusisto H, Paalavuo R, Särkijärvi S, Lehtimäki T, Huhtala H, Vilpo J. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation. Acta Neurol Scand 2006; 113: 163-166.
3. Lehmitz R, Mix E, Jenssen HL. Phagocytic reactivity of granulocytes in the peripheral blood of patients with multiple sclerosis and normal probands. Psychiatr Neurol Med Psychol 1989; 41: 50-53.
4. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol 2001; 58: 91-97.
5. Li H, Newcombe J, Groome NP, Cuzner ML. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993; 19: 214-223.
6. Michałowska-Wender G, Wender M. Mononuclear subsets in the peripheral blood of multiple sclerosis patients in relation to results of brain gadolinium- enhancing imaging. Folia Neuropathol 2006; 44: 67-71.
7. Michałowska-Wender G, Losy J, Szczuciński A, Biernacka-Łukanty J, Wender M. Effect of methylprednisolone treatment on expression of sPECAM-1 and' CXCL10 chemokine in serum of MS patients. Pharmacol Rep 2006; 58: 920-923.
8. Mirowska D, Wicha W, Członkowski A, Członkowska A, Weber F. Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. J Neuroimmunol 2004; 146: 171-175.
9. Mix E, Stefan K, Höppner J, Klauer T, Zettl UK, Strauss U, Meyer-Rienecker HJ, Rolfs A. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta. Autoimmunity 2003; 36: 291-305.
10. Petelin Z, Brinar V, Petravic D, Zurak N, Dubravcic K, Batinic D. CD95/ Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy. Clin Neurol Neurosurg 2004; 106: 259-262.
11. Podikoglou DG, Lianou PE, Tsakanikas CD, Papavassiliou JT. Polymorphonuclear leukocyte functions and multiple sclerosis. Neurology 1994; 44: 129-132.
12. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
13. Prieto A, Díaz D, Barcenilla H, Castrillo C, Monserrat J, Merino AG, Alvarez-Mon M; GENIO II-group. Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis. J Clin Immunol 2006; 26: 101-112.
14. Sharief MK, Douglas M, Noori M, Semra YK. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2002; 125: 155-162.
15. Wang HY, Matsui M, Araya S, Onai N, Matsushima K, Saida T. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. J Neurol Sci 2003; 216: 61-66.
16. Zipp F, Wendling U, Beyer M, Grieger U, Waiczies S, Wagenknecht B, Haas J, Weller M. Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. J Neuroimmunol 2000; 110: 214-222.